ConductScience.org, home

Gene · 11009

IL24: interleukin 24

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. IL24: interleukin 24. Genes, record 11009. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11009

On this page

Gene

Symbol
IL24
HGNC
Name
interleukin 24
HGNC
NCBI Gene ID
11009
NCBI Gene
HGNC ID
HGNC:11346
HGNC
Ensembl
ENSG00000162892
NCBI Gene
Aliases
C49A, FISP, IL-24, IL10B, MDA7, MOB5, Mob-5, ST16, mda-7
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q13007Interleukin-242062Ensembl, GeneID, HGNC

Source UniProt

Patents68

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 12473363 B22025-11-18920Q13007Espacenet
EP 4641202 A22025-10-294724Q13007Espacenet
JP 2025147176 A2025-10-067016Q13007Espacenet
JP 2025529142 A2025-09-046726Q13007Espacenet
US 12371689 B22025-07-296726Q13007Espacenet
JP 2025028160 A2025-02-287016Q13007Espacenet
KR 1020250017231 A2025-02-044724Q13007Espacenet
JP 2025502229 A2025-01-24920Q13007Espacenet
KR 1020250010750 A2025-01-217016Q13007Espacenet
WO 2024249507 A12024-12-0598Q13007Espacenet

1 to 10 of 68

See all 68 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,348

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIL24 papersNewest fiscal year
P30CA016672Cancer Center Support Grant482025
P30CA016059Massey Cancer Center - Cancer Center Support Grant162025
P30CA008748Cancer Center Support Grant62025
U54MD012392RCMI Center for Health Disparities Research62025
P01CA097132Sphingolipids in Cancer Biology and Therapy52025
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center52025
P30CA016087Cancer Center Support Grant52025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success52025
R01CA259599Interplay between tumor and microenvironment in bone metastasis42025
ZIAAI001065India International Center for Excellence in Research42025

1 to 10 of 1,348Source NIH's project files

See all 1,348 nih grants

Papers2,968

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
PRELP-associated transcriptomic remodeling links alternative splicing and immune checkpoint blockade outcome in melanoma.Front Immunol202642813001PubTator, text miningPubMed
Interleukin-24 Induces Inflammatory Chemokine and Cytokine Responses in Fibroblast-Enriched Synovial Cells from Patients with Knee Osteoarthritis.Biomedicines202642792825PubTator, text miningPubMed
BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.J Crohns Colitis202642635600PubTator, text miningPubMed
Potent Inhibition of Dengue Virus Infection by Synthetic Compound TXD-174 Through Specific Targeting of IL-24.J Med Virol202642557990PubTator, text miningPubMed
Plasma IL-24 is associated with time to first fall in Parkinson's disease.J Neuroimmunol202642543049PubTator, text miningPubMed
Target pathway validation for Compound Kushen Injection active against cancer cells.Phytomedicine202642492264PubTator, text miningPubMed
Causal Insights Into Crohn's Disease: The Role of Oxidative Stress and Genetic Variants.J Cell Mol Med202642458727PubTator, text miningPubMed
Exploring the mechanism of interleukin-24 in regulating eosinophil differentiation in chronic obstructive pulmonary disease.Respir Res202642458434PubTator, text miningPubMed
Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer.MedComm (2020)202642415854PubTator, text miningPubMed
Microwave treatment of human papillomavirus-positive in vitro grown epithelial tissues results in a rapid stress-related transcriptional response and induction of innate immunity.Int J Hyperthermia202642381515PubTator, text miningPubMed

1 to 10 of 2,968

See all 2,968 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/11009

GET https://conductscience.org/api/genes/v1/11009/patents?page=2